etoposide has been researched along with Hyperlipemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrera, G; Edwards, PA; Gonzalez, FJ; Lee, FY; Lee, H; Vales, C; Willson, TM; Zhang, Y | 1 |
| Ambruso, DR; Favara, BE; Hays, T; Tubergen, DG; Zwartjes, WJ | 1 |
| Bowman, WP; Brown, RE; Champion, JE; D'Cruz, CA; Pick, TE | 1 |
3 other study(ies) available for etoposide and Hyperlipemia
| Article | Year |
|---|---|
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.
Topics: 3-Hydroxybutyric Acid; Adenoviridae; Animals; Blood Glucose; Blotting, Northern; Blotting, Western; Cholesterol; Diabetes Mellitus, Experimental; DNA-Binding Proteins; Etoposide; Gluconeogenesis; Glucose; Glycogen; Hepatocytes; Hyperglycemia; Hyperlipidemias; Insulin; Insulin Resistance; Isoxazoles; Lipids; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Models, Statistical; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Time Factors; Transcription Factors; Triglycerides | 2006 |
Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213.
Topics: Blood Cell Count; Etoposide; Female; Humans; Hyperlipidemias; Immunoglobulins; Infant; Lymphatic Diseases; Lymphocyte Activation; Male; Phagocytosis; Podophyllotoxin | 1980 |
Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis. Reversal with VP-16 and indomethacin.
Topics: Dinoprost; Dinoprostone; Etoposide; Glucose; Histiocytes; Humans; Hyperlipidemias; Indomethacin; Infant; Lipid Peroxides; Liver; Lymphatic Diseases; Lymphocytosis; Male; Phagocytosis; Prostaglandins E; Prostaglandins F; Vitamin E | 1987 |